IRIS Institutional Research Information System - OPENBS Open Archive UniBS

URBINATI, Chiara Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.220
EU - Europa 2.669
AS - Asia 2.641
SA - Sud America 483
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 10.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.129
PL - Polonia 1.156
SG - Singapore 1.044
CN - Cina 815
BR - Brasile 408
UA - Ucraina 372
HK - Hong Kong 307
DE - Germania 277
IT - Italia 236
VN - Vietnam 171
FI - Finlandia 138
GB - Regno Unito 128
RU - Federazione Russa 90
TR - Turchia 74
IN - India 72
IE - Irlanda 67
FR - Francia 51
CA - Canada 45
BD - Bangladesh 39
AR - Argentina 36
NL - Olanda 33
ID - Indonesia 32
MX - Messico 30
SE - Svezia 28
CZ - Repubblica Ceca 23
ZA - Sudafrica 23
AT - Austria 20
JP - Giappone 17
MA - Marocco 14
EC - Ecuador 12
ES - Italia 12
IL - Israele 11
PK - Pakistan 11
BE - Belgio 10
IQ - Iraq 10
KE - Kenya 7
LT - Lituania 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
EU - Europa 5
IR - Iran 5
PE - Perù 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CO - Colombia 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IS - Islanda 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SN - Senegal 1
TC - Turks e Caicos 1
Totale 10.071
Salva come PNG Salva come JPEG
Città #
Warsaw 1.153
Woodbridge 415
Fairfield 382
Ashburn 374
Singapore 340
Hong Kong 307
Jacksonville 275
Houston 249
Beijing 207
Ann Arbor 194
Cambridge 178
Wilmington 171
Chandler 161
Dallas 161
Seattle 152
New York 133
Princeton 120
Nanjing 97
Los Angeles 87
Dearborn 83
Helsinki 69
Munich 65
Dublin 63
Istanbul 61
Brescia 46
The Dalles 44
Buffalo 42
Dong Ket 42
Milan 42
Ho Chi Minh City 41
San Francisco 39
São Paulo 34
Moscow 33
Jinan 32
Shanghai 32
Nanchang 31
Boardman 30
Chicago 30
Lancaster 30
Shenyang 30
Brooklyn 29
Hanoi 29
Des Moines 26
Redondo Beach 24
San Diego 23
Jiaxing 22
London 22
Tianjin 22
Toronto 22
Santa Clara 21
Changsha 20
Kunming 18
Nuremberg 18
Hebei 17
Jakarta 17
Phoenix 17
Turku 16
Verona 16
Zhengzhou 16
Hangzhou 15
Olomouc 15
Rio de Janeiro 15
Tokyo 15
Council Bluffs 14
Johannesburg 14
Atlanta 13
Florence 13
Groningen 13
Manchester 13
Poplar 13
Stockholm 13
Chennai 12
Denver 12
Haikou 12
Lallio 12
Montreal 11
Augusta 10
Brussels 10
Guangzhou 9
Leawood 9
San Mateo 9
Belo Horizonte 8
Dhaka 8
Frankfurt am Main 8
Mexico City 8
Ningbo 8
Taizhou 8
Brno 7
Guayaquil 7
Hải Dương 7
Lanzhou 7
Mumbai 7
Querétaro 7
Amsterdam 6
Ankara 6
Beersheba 6
Boston 6
Brasília 6
Charlotte 6
Coimbatore 6
Totale 6.874
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 338
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 292
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 283
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 263
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 261
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 249
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 248
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 209
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 197
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 197
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 197
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 193
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 191
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 179
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 179
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 161
Sialic acid as a target for the development of novel antiangiogenic strategies 161
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 159
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 158
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 153
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 148
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 144
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 138
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 136
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable" 131
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 130
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 129
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 128
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 125
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity 119
Role of heparan sulfate proteoglycans in HIV-1 Tat-induced transendothelial migration of lymphoid cells 119
Recent Strategic Advances in CFTR Drug Discovery: An Overview 115
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 114
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein 109
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF-receptors 109
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 108
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 108
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 104
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF. 103
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis 102
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain 102
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 102
The basic domain in HIV-1 Tat as a target for polysulfated heparin-mimicking extracellular Tat antagonists 99
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 95
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 95
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 93
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 91
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 88
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 88
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells 88
Thrombospondin/HIV-1 Tat protein interaction: modulation of the biologiocal activity of extracellular Tat 87
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes 86
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium 84
Thrombospondin-1: the paradigm of antiangiogenic agents endowed with multiple mechanisms of action 83
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 83
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein 80
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes 79
Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: biological activity and intracellular fate of human recombinant Mr 24,000 bFGF 79
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 77
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin 75
Glycomics and angiogenesis: biological implications and therapeutical exploiting 72
heparan sulfate proteoglycans/HIV-1 Tat interaction: a mechanical and functional bridge between lymphoid and endothelial cells 72
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 70
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms 70
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS 69
HIV-1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension of its biological functions 68
DOES NICOTINAMIDE COMBINES WITH LUMACAFTOR TO IMPROVE F508del-CFTR RESCUE? 66
multidisciplinary approaches to rescue CFTR impairments by drug repositioning 66
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 65
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration 65
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study 64
UV-C EXPOSURE SUGGESTS A SARS-CoV-2 SPIKE PROTEIN ANTIVIRAL STRATEGY BASED ON REDUCING AGENTS 61
Exploring Alternative BAG3 Targeting Approaches for pediatric medulloblastoma: From small molecules lead optimization to Fragment-Based Drug Discovery 59
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers 59
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 57
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays 56
Computational evaluation of the synergic effect of a small molecule on Lumacaftor F508del-CFTR rescue ability 55
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 54
Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples 50
HIV-1 Tat and heparan sulfate proteoglycans orchestrate the setup of in cis and in trans cells surface interactions functional to lymphocyte trans-endothelial migration 50
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 49
HIV-of its biological functions1 Tat/heparin interaction: translating new insight from molecular modelling to the comprehension 48
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 48
implementation of an incremental docking method to study long sugar chains interactions with proteins 45
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 44
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 42
A drug repositioning pipeline to evaluate a synergic effect of small molecules on CFTR drugs 40
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound 35
Role of thrombospondin-1 in the microenvironment of osteolytic bone metastases 33
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 33
Totale 10.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021706 0 0 0 0 0 124 42 140 131 79 115 75
2021/2022540 15 108 8 16 5 29 40 40 24 75 44 136
2022/2023438 64 19 26 19 29 125 7 46 63 3 12 25
2023/2024618 36 8 63 35 28 122 17 20 139 16 17 117
2024/20251.798 20 10 7 188 94 109 117 54 139 246 524 290
2025/20262.278 389 521 355 570 399 44 0 0 0 0 0 0
Totale 10.234